Harmony Biosciences Holdings (HRMY)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 557,919 | 536,321 | 521,033 | 489,571 | 460,786 | 436,949 | 403,224 | 382,123 | 354,374 | 326,347 | 298,228 | 271,255 | 249,923 | 222,897 | 194,488 |
| Revenue (ttm) | US$ in thousands | 710,199 | 672,548 | 630,000 | 585,184 | 548,499 | 507,747 | 476,532 | 451,378 | 419,060 | 383,158 | 319,980 | 290,957 | 268,890 | 236,824 | 233,336 |
| Gross profit margin | 78.56% | 79.74% | 82.70% | 83.66% | 84.01% | 86.06% | 84.62% | 84.66% | 84.56% | 85.17% | 93.20% | 93.23% | 92.95% | 94.12% | 83.35% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $557,919K ÷ $710,199K
= 78.56%
The gross profit margin of Harmony Biosciences Holdings has displayed variations over the period covered. Starting at 83.35% in June 2021, the margin increased to reach a peak of 94.12% by September 2021. Subsequently, there was a slight decrease, stabilizing in the range of 92-93% for the following quarters up to March 2023. However, a downward trend began, with the gross profit margin declining to around 78-79% by December 2024. This downward trend indicates potential challenges in maintaining profitability or controlling production costs. It would be crucial for Harmony Biosciences Holdings to address these declines and possibly implement strategies to improve their gross profit margin to ensure sustainable financial performance.
Peer comparison
Dec 31, 2024